Brookfield Corp’s Chemours CC Stock Holding History

Brookfield Corp’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-26,962	Closed	-$905K	–	640
2021 Q4	$905K	Buy	+26,962	New	+$840K	﹤0.01%	469
2020 Q3	–	Sell	-25,000	Closed	-$384K	–	381
2020 Q2	$384K	Buy	+25,000	New	+$316K	﹤0.01%	322

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Brookfield Corp's CC Position: Q1 2022 in Review

Brookfield Corp sold out of Chemours (CC) in Q1 2022, closing a stake of 26,962 shares — an estimated $905K sold.

Brookfield Corp first reported a position in CC in Q2 2020 and held it in 2 quarters. The position peaked at $905K in Q4 2021. 482 funds tracked by Wall St. Rank hold CC as of Q1 2022.

Brookfield Corp reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
Brookfield Corp sold 26,962 Chemours shares in Q1 2022, an estimated $905K.
Brookfield Corp first reported a position in Chemours in Q2 2020 and held it in 2 quarters.
Brookfield Corp's Chemours position peaked at $905K in Q4 2021.
482 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Brookfield Corp's 13F filing for Q1 2022, filed 16 May 2022.